Clinical Trial Update: Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 randomized crossover PK study comparing subcutaneous versus intravenous granisetron in cancer patients undergoing chemotherapy, evaluating pharmacokinet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Granisetron (granisetron)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Vomiting | Phase 2 | Status: COMPLETED